TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from JBM (Healthcare) Ltd. ( (HK:2161) ) is now available.
JBM (Healthcare) Limited has announced the re-designation of Mr. Sum Kwong Yip, Derek, and Mr. Yim Chun Leung from non-executive to executive directors, effective June 12, 2025. This move is expected to enhance the company’s strategic direction and operational management, leveraging the extensive experience of both individuals in the pharmaceutical and corporate finance fields.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited operates in the healthcare industry, focusing on pharmaceutical products and services. The company is involved in strategic planning and development within the pharmaceutical sector, leveraging extensive experience in sales and corporate management.
Average Trading Volume: 1,275,497
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.13B
For detailed information about 2161 stock, go to TipRanks’ Stock Analysis page.